- CA$7.08m
- CA$2.98m
- 33
- 42
- 48
- 35
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.4 | 3.03 | 3.48 | 10.3 | 7.64 |
Operating Profit | -3.4 | -3.03 | -3.48 | -10.3 | -7.64 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.34 | -3.03 | -3.36 | -9.65 | -7.15 |
Net Income After Taxes | -3.34 | -3.03 | -3.36 | -9.65 | -7.15 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.34 | -3.03 | -3.36 | -9.65 | -7.15 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.34 | -3.03 | -3.36 | -9.65 | -7.15 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.059 | -0.042 | -0.029 | -0.037 | -0.029 |